• We are catalysts for innovation, commercialising next-generation technologies developed by

    The University of Manchester’s world-class research base





    • £360m+ invested by venture funders

    • 40+ spin-out companies created

    • 7,500+ licences and IP partnerships concluded

    • 4,000+ invention disclosures received

    • £115m+ IP and R&D revenue generated for the University







  • We are catalysts for innovation, commercialising next-generation technologies developed by The University of Manchester’s world-class research base





    • £300m+ invested by venture funders since 2004

    • 40+ spin-out companies created

    • 4,800+



      licences and IP partnerships concluded

    • 3,700+ invention disclosures received

    • 1,300+ jobs generated across various industry sectors

    • £105m+ IP and R&D revenue generated for the University


Archive for January, 2011

Shadow Minister for Innovation & Science visits UMIP and UMIC

Chi Onwurah, the Shadow Minister for Innovation & Science (Business, Innovation and Skills Team) and MP for Newcastle Upon Tyne Central, visited The University of Manchester’s intellectual property commercialisation company (UMIP) and its business incubation company (UMIC) on Monday 10th January 2011.

Having discussed education, innovation and enterprise with the Deputy President and Deputy Vice-Chancellor Professor Rod Coombs and Clive Rowland, CEO of UMIP, Ms Onwurah commented: “Innovation is the engine of growth and progress. I was impressed by the work UMIP is doing to commercialise innovation and help us keep our place at the forefront of world science. Universities, small local businesses, global companies and financiers all need to be able to work together to cross fertilise ideas, enable innovation and growth. I hope UMIP can continue to work with all stakeholders in this way.”
Ms Onwurah enjoyed a guided tour of one of UMIC’s bioscience incubators, The Core Technology Facility, where she was introduced to John Nicholson, Chairman and CEO, and Professor Richard Walmsley, Chief Scientific Officer, of University spin-out company, Gentronix Ltd, an innovative biotechnology company.
“An innovation which means we don’t need to use animal tissue in testing for carcinogens, and is so much cheaper than traditional tests, has to be a real step forward. I’m glad the University was able to support Gentronix in its early days. We need more early day support for innovative companies,” said Ms Onwurah.

CONTACT US